Physician profile
Devon E Schneider
NPI 1891070207
$404.68
in general payments reported to CMS, 2019-2025
10 companies · $90.98 in 2025
The $90.98 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $157 · 2024: $157 · 2025: $90.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $118.27 | 2023-2024 | Shingrix |
| Otsuka America Pharmaceutical, INC. | $62.50 | 2023-2024 | Rexulti |
| Lilly USA, LLC | $45.87 | 2023-2024 | Mounjaro, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.10 | 2025 | Caplyta |
| Exact Sciences Corporation | $30.39 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $30.23 | 2024 | |
| Pfizer INC. | $24.00 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.14 | 2024 | Voquezna |
| Organon LLC | $16.49 | 2025 | Nexplanon |
| Novo Nordisk INC | $14.69 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.